Fredun Pharma Allots 3,61,599 Equity Shares on Warrant Conversion

Fredun Pharmaceuticals Ltd's Board of Directors, in a meeting held on September 16, 2026, has allotted 3,61,599 Equity Shares of face value ₹10 each. This allotment is a result of the conversion of 1,20,533 convertible warrants. These warrants were initially allotted on a preferential basis on December 29, 2025, following shareholder approval. The warrant holders paid the balance consideration and exercised their rights for conversion. The entitlement for conversion was adjusted after the company's 1:2 bonus issue, leading to each warrant converting into three equity shares. The newly allotted shares will be in dematerialized form and rank pari passu with existing equity shares.